A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris
Authors:
- James L JanuzziJJJames L Januzzi
- Stephen SnapinnSSStephen Snapinn
- Pierre ThérouxPTPierre Théroux
- Ik-Kyung JangIJIk-Kyung Jang
- 1 September 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (5) , 488-492
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Unstable Angina PectorisNew England Journal of Medicine, 2000
- Usefulness of hospital admission risk stratification for predicting nonfatal acute myocardial infarction or death six months later in unstable angina pectorisThe American Journal of Cardiology, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre studyThe Lancet, 1999
- Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database studyEuropean Heart Journal, 1999
- Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3American Heart Journal, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Risk Stratification in Unstable AnginaJAMA, 1995